Maxalt-mlt
Product Images NDC 54868-4499

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Maxalt-mlt (NDC 54868-4499). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Maxalt Tablets)

FDA Label Image

Principal Display Panel (Maxalt-MLT Tablets)

Principal Display Panel (Maxalt-MLT Tablets)
This appears to be a product information label which includes details about the distribution and identification of a medical product. The product is distributed by "Prysicians Total Care" and has an NDC code of 54868-4499-0. The label also includes a product identification code "HARALT-HLT 164G", a lot number, and an expiration date (whose format looks incorrect). There is also an "R" symbol, which typically indicates a trademark registration. The label ends with a series of numbers that could possibly be a product quantity or a further identification number.*
FDA Label Image

Image Of Rizatriptan Benzoate Chemical Structure (Maxalt 01)

FDA Label Image

Image Of Figure 1 (Maxalt 02)

FDA Label Image

Image Of Figure 2 (Maxalt 03)

Image Of Figure 2 (Maxalt 03)
This appears to be a graph showing the estimated probability of remediating or rescuing a certain situation or system. The graph uses percentages and appears to have several data points along a time axis. Without additional context or labels, it is difficult to determine the exact meaning or significance of the data.*
FDA Label Image

Image Of Figure 3 (Maxalt 04)

Image Of Figure 3 (Maxalt 04)
This text appears to be a graph showing the estimated probability of response for a medication called MAXALT-MLT compared to a placebo. It shows the probability of response at different hours post-dose, with the highest probability being 100%.*
FDA Label Image

Image Of Figure 4 (Maxalt 05)

Image Of Figure 4 (Maxalt 05)
This text appears to be a graph or chart showing the Estimated Probability of Remediation or Rescue for a medication called MAXALT-MLT. It shows the probability percentages over a certain period of time (10-24 hours post-dose) and features two dosage options (MAXALT-MLTS mg and MAXALT-MLT 10 mg). Additionally, there is a photo included, though its subject is unknown without context.*
FDA Label Image

Image Of Figure 5 (Maxalt 06)

Image Of Figure 5 (Maxalt 06)
The text appears to be a table showing the percentage value with a confidence level of 95% for two conditions (MAXALTMLT and Placeho) at different time intervals (0, 10, 15, and 20 hours after the Stage 2 Dose). However, without the context and information about what condition or treatment is being studied, it is not possible to provide a more specific description.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.